Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | AGIO |
---|---|---|
09:32 ET | 3699 | 44.525 |
09:34 ET | 3200 | 44 |
09:36 ET | 1500 | 43.28 |
09:38 ET | 1450 | 43.39 |
09:39 ET | 6403 | 43.18 |
09:41 ET | 300 | 43.32 |
09:43 ET | 1000 | 43.01 |
09:45 ET | 1000 | 43.03 |
09:48 ET | 3180 | 43.13 |
09:50 ET | 1100 | 43.14 |
09:52 ET | 9937 | 43.4 |
09:54 ET | 1945 | 43.25 |
09:56 ET | 1749 | 43.38 |
09:57 ET | 1100 | 43.37 |
09:59 ET | 798 | 43.6 |
10:01 ET | 2698 | 44.01 |
10:03 ET | 900 | 44.07 |
10:06 ET | 324 | 44.17 |
10:08 ET | 1500 | 43.81 |
10:10 ET | 500 | 43.82 |
10:12 ET | 1601 | 43.56 |
10:15 ET | 100 | 43.51 |
10:17 ET | 100 | 43.38 |
10:19 ET | 900 | 43.26 |
10:24 ET | 1700 | 43.39 |
10:26 ET | 550 | 43.34 |
10:28 ET | 5336 | 43.365 |
10:30 ET | 100 | 43.33 |
10:32 ET | 1450 | 43.432 |
10:33 ET | 2543 | 43.22 |
10:35 ET | 1401 | 43.29 |
10:37 ET | 300 | 43.32 |
10:39 ET | 807 | 43.3 |
10:42 ET | 900 | 43.185 |
10:44 ET | 2249 | 43.23 |
10:46 ET | 300 | 43.17 |
10:48 ET | 916 | 43 |
10:50 ET | 615 | 43 |
10:51 ET | 613 | 42.975 |
10:53 ET | 2260 | 42.9 |
10:55 ET | 2394 | 42.945 |
10:57 ET | 500 | 42.91 |
11:00 ET | 2229 | 42.98 |
11:02 ET | 1700 | 42.93 |
11:04 ET | 642 | 42.88 |
11:06 ET | 300 | 42.815 |
11:08 ET | 1250 | 42.68 |
11:09 ET | 200 | 42.64 |
11:11 ET | 1000 | 42.71 |
11:13 ET | 1955 | 42.725 |
11:15 ET | 1700 | 42.785 |
11:18 ET | 500 | 42.67 |
11:20 ET | 200 | 42.71 |
11:22 ET | 6298 | 42.6 |
11:24 ET | 1689 | 42.73 |
11:26 ET | 1271 | 42.59 |
11:27 ET | 500 | 42.74 |
11:29 ET | 673 | 42.7 |
11:31 ET | 686 | 42.905 |
11:33 ET | 100 | 42.885 |
11:36 ET | 200 | 42.985 |
11:38 ET | 2523 | 42.945 |
11:40 ET | 732 | 42.955 |
11:42 ET | 2040 | 42.835 |
11:44 ET | 300 | 42.77 |
11:45 ET | 1707 | 42.84 |
11:47 ET | 400 | 42.835 |
11:49 ET | 754 | 42.84 |
11:51 ET | 200 | 42.85 |
11:54 ET | 300 | 42.86 |
11:56 ET | 500 | 42.905 |
11:58 ET | 200 | 42.93 |
12:00 ET | 400 | 42.975 |
12:02 ET | 2024 | 42.86 |
12:03 ET | 1100 | 43.04 |
12:05 ET | 300 | 43.125 |
12:07 ET | 100 | 43.195 |
12:09 ET | 100 | 43.215 |
12:12 ET | 700 | 43.23 |
12:14 ET | 3900 | 43.39 |
12:16 ET | 700 | 43.28 |
12:18 ET | 100 | 43.36 |
12:20 ET | 1006 | 43.37 |
12:21 ET | 200 | 43.44 |
12:23 ET | 100 | 43.49 |
12:25 ET | 100 | 43.48 |
12:27 ET | 300 | 43.495 |
12:30 ET | 2268 | 43.42 |
12:32 ET | 100 | 43.41 |
12:36 ET | 1900 | 43.49 |
12:38 ET | 200 | 43.56 |
12:39 ET | 400 | 43.39 |
12:41 ET | 700 | 43.41 |
12:43 ET | 100 | 43.36 |
12:45 ET | 500 | 43.365 |
12:48 ET | 600 | 43.16 |
12:52 ET | 100 | 43.18 |
12:54 ET | 500 | 43.31 |
12:56 ET | 400 | 43.34 |
12:57 ET | 1924 | 43.485 |
01:01 ET | 100 | 43.51 |
01:03 ET | 3209 | 43.41 |
01:06 ET | 100 | 43.42 |
01:08 ET | 1785 | 43.23 |
01:10 ET | 100 | 43.22 |
01:12 ET | 200 | 43.22 |
01:14 ET | 100 | 43.265 |
01:15 ET | 100 | 43.255 |
01:17 ET | 709 | 43.188 |
01:19 ET | 100 | 43.14 |
01:21 ET | 200 | 43.17 |
01:24 ET | 405 | 43.13 |
01:26 ET | 300 | 43.03 |
01:30 ET | 2534 | 42.98 |
01:32 ET | 100 | 43 |
01:33 ET | 1350 | 43.11 |
01:37 ET | 700 | 42.99 |
01:39 ET | 508 | 42.93 |
01:44 ET | 100 | 42.975 |
01:46 ET | 800 | 43.06 |
01:48 ET | 200 | 43.055 |
01:50 ET | 9476 | 43.24 |
01:51 ET | 1500 | 43.01 |
01:55 ET | 300 | 43.07 |
01:57 ET | 500 | 43.085 |
02:00 ET | 384 | 43.16 |
02:02 ET | 900 | 43.12 |
02:04 ET | 1000 | 43.13 |
02:06 ET | 201 | 43.1 |
02:09 ET | 4540 | 43.19 |
02:11 ET | 1376 | 43.23 |
02:13 ET | 200 | 43.23 |
02:15 ET | 1000 | 43.31 |
02:18 ET | 500 | 43.39 |
02:20 ET | 1100 | 43.31 |
02:22 ET | 300 | 43.31 |
02:24 ET | 800 | 43.23 |
02:26 ET | 2150 | 43.18 |
02:27 ET | 861 | 43.115 |
02:29 ET | 100 | 43.115 |
02:31 ET | 1100 | 43.14 |
02:33 ET | 300 | 43.13 |
02:36 ET | 610 | 43.09 |
02:38 ET | 1200 | 43 |
02:40 ET | 100 | 43 |
02:42 ET | 100 | 42.97 |
02:44 ET | 200 | 43.03 |
02:45 ET | 1150 | 43.055 |
02:47 ET | 418 | 43.115 |
02:49 ET | 500 | 43.17 |
02:51 ET | 2400 | 43 |
02:54 ET | 900 | 42.89 |
02:56 ET | 2400 | 42.795 |
02:58 ET | 1947 | 42.8 |
03:00 ET | 1300 | 42.805 |
03:02 ET | 2537 | 42.71 |
03:03 ET | 1000 | 42.91 |
03:05 ET | 3182 | 42.955 |
03:07 ET | 1179 | 42.85 |
03:09 ET | 400 | 42.915 |
03:12 ET | 673 | 42.92 |
03:14 ET | 200 | 42.95 |
03:16 ET | 1302 | 42.86 |
03:18 ET | 4784 | 42.75 |
03:20 ET | 370 | 42.805 |
03:21 ET | 1200 | 42.695 |
03:23 ET | 2684 | 42.71 |
03:25 ET | 100 | 42.68 |
03:27 ET | 369 | 42.765 |
03:30 ET | 16976 | 42.77 |
03:32 ET | 1200 | 42.65 |
03:34 ET | 900 | 42.72 |
03:36 ET | 1200 | 42.715 |
03:38 ET | 600 | 42.805 |
03:39 ET | 2442 | 42.76 |
03:41 ET | 403 | 42.73 |
03:43 ET | 8340 | 42.61 |
03:45 ET | 4055 | 42.55 |
03:48 ET | 1100 | 42.625 |
03:50 ET | 5380 | 42.505 |
03:52 ET | 3957 | 42.49 |
03:54 ET | 5392 | 42.52 |
03:56 ET | 13422 | 42.53 |
03:57 ET | 9330 | 42.44 |
03:59 ET | 100730 | 42.47 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Agios Pharmaceuticals Inc | 2.5B | -6.5x | --- |
IDEAYA Biosciences Inc | 2.7B | -14.1x | --- |
CG Oncology Inc | 2.5B | -31.6x | --- |
Structure Therapeutics Inc | 2.5B | -18.9x | --- |
Edgewise Therapeutics Inc | 2.5B | -17.8x | --- |
Immunitybio Inc | 2.6B | -3.8x | --- |
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and delivering transformative therapies for patients living with rare diseases. It markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for debilitating hemolytic anemia. Its lead product candidate in its genetically defined disease (GDD) portfolio, PYRUKYND (Mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the treatment of hemolytic anemias. The Mitapivat is an orally available small molecule and a potent activator of the pyruvate kinase R (PKR) enzymes. In addition, it is also evaluating mitapivat for the treatment of alpha- and beta- thalassemia and sickle cell disease (SCD) in ongoing clinical trials. The Company is also developing AG-946, a clinical-stage oral activator of PKR enzymes for the treatment of hemolytic anemias and other indications, including SCD.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.5B |
---|---|
Revenue (TTM) | $31.3M |
Shares Outstanding | 56.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.75 |
EPS | $-6.49 |
Book Value | $14.50 |
P/E Ratio | -6.5x |
Price/Sales (TTM) | 80.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,293.88% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.